Therefore, omeprazole may serve as a novel Hh/Gli1 inhibitor, and should be useful for further development of drugs targeting miR-203a-3p/Gli1 by employing omeprazole as the lead compound for treatment and chemoprevention of BE. The gene discussed is GLI1; the disease is Barrett esophagus.